1. Home
  2. C vs AZN Comparison

C vs AZN Comparison

Compare C & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citigroup Inc.

C

Citigroup Inc.

N/A

Current Price

$132.64

Market Cap

220.2B

Sector

Finance

ML Signal

N/A

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

N/A

Current Price

$182.74

Market Cap

316.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
C
AZN
Founded
1812
1992
Country
United States
United Kingdom
Employees
226000
96100
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.2B
316.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
C
AZN
Price
$132.64
$182.74
Analyst Decision
Buy
Strong Buy
Analyst Count
16
1
Target Price
$134.94
N/A
AVG Volume (30 Days)
7.5M
1.8M
Earning Date
04-14-2026
04-29-2026
Dividend Yield
1.88%
1.73%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.26
$10.34
Revenue Next Year
$3.63
$6.43
P/E Ratio
$16.63
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$76.11
$68.62
52 Week High
$135.83
$212.71

Technical Indicators

Market Signals
Indicator
C
AZN
Relative Strength Index (RSI) 61.74 46.87
Support Level $118.07 $180.98
Resistance Level $133.62 $191.50
Average True Range (ATR) 3.45 3.14
MACD 0.76 0.13
Stochastic Oscillator 82.67 48.05

Price Performance

Historical Comparison
C
AZN

About C Citigroup Inc.

Citigroup is a global financial powerhouse that orchestrates the movement of $5 trillion in daily transaction volume, serving as the essential connective tissue for the world's most complex multinational corporations. The firm remains a leader on the global stage, servicing 90% of the Fortune 500 through a proprietary network that includes direct membership to over 270 cash-clearing centers and a footprint that spans 94 countries. After a checkered history operating as an overly complex, disjointed firm, steps have been taken to streamline operations, resulting in organization across five segments: services, markets, banking, wealth, and US personal banking.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: